Safety Study of BMX-001 (Radio-protector) in Patients With Newly Diagnosed Anal Cancer

NCT03386500 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Anal Cancer, Squamous Cell Carcinoma
Radiation Exposure

Interventions

DRUG: BMX-001

Sponsor

University of Nebraska

Collaborators

[object Object]